Development of Donor Recipient Chimeric Cells of bone marrow origin as a novel approach for tolerance induction in transplantation.
Stem cell investigation(2021)
摘要
This study confirmed feasibility of DRCC creation via PEG mediated fusion. The created DRCC revealed pro-tolerogenic properties indicating potential immunomodulatory effect of DRCC therapy when applied to support tolerance induction in solid organ and vascularized composite allograft transplantation.
更多查看译文
关键词
Donor recipient chimeric cell (DRCC),cell fusion,cell therapy,immunomodulation,transplantation
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要